54 related articles for article (PubMed ID: 9070211)
1. DDT stimulates c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation, and proliferation of human breast epithelial cells.
Shen K; Novak RF
Biochem Biophys Res Commun; 1997 Feb; 231(1):17-21. PubMed ID: 9070211
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
Tari AM; Hung MC; Li K; Lopez-Berestein G
Oncogene; 1999 Feb; 18(6):1325-32. PubMed ID: 10022814
[TBL] [Abstract][Full Text] [Related]
3. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
4. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
5. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
6. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
7. Fas-signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells.
Shen K; Novak RF
Biochem Biophys Res Commun; 1997 Jan; 230(1):89-93. PubMed ID: 9020068
[TBL] [Abstract][Full Text] [Related]
8. Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells.
Ogata A; Chauhan D; Urashima M; Teoh G; Treon SP; Anderson KC
Clin Cancer Res; 1997 Jun; 3(6):1017-22. PubMed ID: 9815779
[TBL] [Abstract][Full Text] [Related]
9. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
10. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
11. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2.
Pei Z; Maloney JA; Yang L; Williamson JR
Arch Biochem Biophys; 1997 Sep; 345(1):103-10. PubMed ID: 9281317
[TBL] [Abstract][Full Text] [Related]
12. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
[TBL] [Abstract][Full Text] [Related]
13. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
15. Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells.
Lim SJ; Lopez-Berestein G; Hung MC; Lupu R; Tari AM
Oncogene; 2000 Dec; 19(54):6271-6. PubMed ID: 11175341
[TBL] [Abstract][Full Text] [Related]
16. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
Fiddes RJ; Janes PW; Sanderson GM; Sivertsen SP; Sutherland RL; Daly RJ
Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
[TBL] [Abstract][Full Text] [Related]
17. Activation of c-Neu tyrosine kinase by o,p'-DDT and beta-HCH in cell-free and intact cell preparations from MCF-7 human breast cancer cells.
Enan E; Matsumura F
J Biochem Mol Toxicol; 1998; 12(2):83-92. PubMed ID: 9443065
[TBL] [Abstract][Full Text] [Related]
18. Receptor tyrosine kinases and their targets.
Kazlauskas A
Curr Opin Genet Dev; 1994 Feb; 4(1):5-14. PubMed ID: 8193540
[TBL] [Abstract][Full Text] [Related]
19. Heptachlor and o-p'DDT effects on protein kinase activities associated with human placenta particulate fractions.
Magnarelli G; Souza MS; de D'Angelo AM
J Biochem Mol Toxicol; 2009; 23(3):185-92. PubMed ID: 19526567
[TBL] [Abstract][Full Text] [Related]
20. Increased ErbB-2 tyrosine kinase activity, MAPK phosphorylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides.
Tessier DM; Matsumura F
Toxicol Sci; 2001 Mar; 60(1):38-43. PubMed ID: 11222871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
